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characteristics of weakly basic drugs with different pKa and 
aqueous solubilities at the pH of interest (7.4) were also 
investigated for their release from hydrophilic matrices.[5] 
These excipients either increase the release of drug from 
the delivery system by leaching out at higher pH values 
or keeping the pH low within the system in the intestinal 
pH range and thus the solubility of the drug high. One 
approach to overcome the problem of pH-dependent drug 
release is demonstrated in this paper, i.e., using common 
organic acids to create an acidic pH inside the polymer 
matrices.
Diltiazem hydrochloride is a calcium channel blocker 
presently considered an important drug for the treatment 
INTRODUCTION
Many drugs are weak bases or salts thereof and thus 
demonstrate pH-dependent solubility in the pH range 
of the GI tract. With controlled-release dosage forms, 
a possible pH-dependent release could result in in vivo 
variability and bioavailability problems.[1,2] Hence, pH-
independent release of drug is desirable to better assure a 
reliable drug therapy and to build a greater control into a 
dosage form. Several attempts to overcome the problem of 
pH-dependent solubility of weakly basic drugs have been 
published. They are mostly based on the presence of acidic 
excipients such as water soluble or insoluble polymers or 
organic acids.[3,4] The effect of enteric polymers on release 
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ABSTRACT
The matrix tablets of diltiazem hydrochloride were prepared by direct compression using hydroxypropyl methyl 
cellulose (HPMC) and various amounts (2.5%, 5.0%, 10% and 20%) of citric acid, malic acid and succinic acid. 
The characterization of physical mixture of drug and organic acids was performed by Infra-red spectroscopy. An 
organic acid was incorporated to set up a system bringing about gradual release of this drug. The influence of 
organic acids on the release rate were described by the Peppas equation: Mt/M∞ = Ktn and Higuchi’s equation: 
Qt   = K1t1/2. The addition of organic acids and the pH value of medium could notably influence the dissolution 
behavior and mechanism of drug-release from matrices. Increasing amounts of organic acid produced an 
increase in drug release rate, which showed a good linear relationship between contents of organic acid and 
drug accumulate release (%) in phosphate buffer, pH 7.4. The drug release increased significantly (P < 0.05) with 
use of succinic acid in tablet formulation. Increasing amounts of succinic acid above 10% produced decreasing 
values of n and increasing values of k, in a linear relationship, which indicated there was a burst release of drug 
from the matrix. Optimized formulations are found to be stable upon 3-month study.
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of hypertension. In the case of hypertension, successful 
treatment can be achieved only by maintaining blood pressure 
at a normal physiological level, and for this a constant and 
uniform supply of drug is desired. Diltiazem hydrochloride 
with all evident advantages proved to be a suitable candidate 
for development of a controlled-release dosage form, but the 
solubility of diltiazem hydrochloride is pH-dependent could 
result in vivo variability and bioavailability problems.[6] HPMC 
K-15M is employed to formulate controlled-release tablets 
of diltiazem hydrochloride since it could retard the release 
up to 24 h. The solubility of HPMC is pH-independent and 
forms a strong viscous gel on contact with aqueous media, 
which may be useful in controlled delivery of highly water-
soluble drugs.[7,8]
MATERIALS AND METHODS
Diltiazem hydrochloride was a gift sample from Anglo-
French Drugs (Bangalore, India). Hydroxypropyl methyl 
cellulose (Methocel®, K-15M) was a gift sample from 
BPRL Private Ltd (Bangalore, India). The organic acids 
used were citric acid (Eros Pharma, Bangalore, India), 
malic acid (Lake Pharma, Bangalore, India), and succinic 
acid (Nice Chemicals, Mumbai, India). The lactose (Nice 
Chemicals, Mumbai, India), magnesium stearate (Loba 
Chemie, Mumbai, India), and all other reagents used in 
the study were laboratory grade.
Formulation of tablets
Weighed quantity of drug, polymer, diluent, and one of the 
organic acids were mixed in geometric proportion. Amount 
of each ingredient was added as per Table 1, granules were 
prepared using water as a granulating fluid. Granules were 
dried and lubricated with 0.5% w/w magnesium stearate 
for 3 min. Then, 450 mg of lubricated granules were 
compressed with 10-station Rimek Minipress RSB-1 tablet 
punching machine using flat-faced punches (12 mm dia.). 
Characteristics of blend-like bulk density, compressibility 
index, and angle of repose were determined for each 
formulation. The dimensional specifications were measured 
using thickness gauge (Okimoto); weight variation test was 
conducted as per IP specifications. Hardness of the tablet 
was measured by using Pfizer hardness tester.
Characterization by Infra-red spectroscopy
Infra-red spectra for drug and organic acids were obtained 
on a infra-red spectrophotometer, model-8400S, Shimadzu 
Corporation, Kyoto, Japan, in the range of 4600–400 cm–1 
[Figure 1] with resolution of 4.0 cm–1. KBr pellets were 
prepared by gently mixing the sample with KBr (1:100) 
and pressing the pellets at the pressure of 150 kg/cm2 
using pelletizer.
Drug content determination
Tablet triturate equivalent to 85 mg of diltiazem hydrochloride 
was dissolved in 100 mL of 0.1 N HCl in volumetric flask, 
warmed at 50 °C for 30 min and filtered through 0.45 μm 
membrane filter. Sufficient dilutions were made from the 
filtrate to obtain 8 µg/mL solution. Absorbance of the 
resulting solution was measured using (UV1800 ENG240V 
shimadzu) spectrophotometer at 236 nm.
Swelling behavior of matrix tablets
The extent of swelling was measured in terms of percent 
weight gain by the tablet.[9] The swelling behavior of 
formulation F1, F4, F5 and F12 were studied. One tablet from 
each formulation was kept in a beaker containing 100 mL 
of pH 7.4 phosphate buffer. At the end of 1 h, the tablet 
was withdrawn, soaked with tissue paper and weighed. 
Then for every 2 h, weights of the tablets were noted and 
process was continuous till the end of 12 h. The percentage 
weight gain by the tablet was calculated by formula
SI = {(Mt - Mo)/Mo} × 100, 
where SI is swelling index, Mt is the weight of tablet at time 
“t”, and Mo is the weight of tablet at time “t”=0.
In vitro drug release studies
The in vitro dissolution studies were carried out by USP 24 
dissolution apparatus type II paddle at 50 rpm. Dissolution 
test was carried out for a total period of 12 h using, 0.1 N 
HCl (pH 1.2) solution (900 mL) as dissolution medium at 
37°  0.5° for first 2 h, and pH 7.4 phosphate buffer solution 
(900 mL) for rest of the of period. Five milliliters of the 
sample was withdrawn at regular intervals and replaced with 
the same volume prewarmed (37° ± 0.5°) fresh dissolution 
Figure 1: FT-IR spectra of diltiazem (DTZ) HCL, citric acid (CA), malic 
acid (MA), succinic acid (SA), and physical mixture of DTZ with CA, 
MA, and SA, respectively
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medium. The samples withdrawn were filtered through 
0.45 μm membrane filter, and drug content in each sample 
was analyzed after suitable dilution. The actual content in 
samples was read from a calibration curve prepared with 
standard diltiazem hydrochloride.[10]
Solubility determination
Solubility measurements of diltiazem hydrochloride were 
conducted in the pH range from 2.0 to 8.0 at 37°. An excess 
finely powdered drug was added to buffer solution of 
respective pH. The flasks were closed tightly and agitated 
at constant temperature (37° ± 1°) for 72 h. The solutions 
were filtered using 0.45 μm membrane filter and drug 
concentration in the filtrate was determined using UV-
spectrophotometer. Solubility measurements of organic 
acids were also determined spectrophotometrically.[10-11]
Kinetic analyses of dissolution data
The commonly adopted model for understanding release 
behavior of a drug from hydrophilic matrix is a simple 
exponential equation. The in vitro drug release data were 
fitted into Korsmeyer–Peppas equation[12]  Mt/M∞ = Ktn, 
where Mt/M∞ corresponds to the amount of drug released 
at time t and after an infinite time, K is a constant related 
to the structural and geometric properties of the drug 
delivery system (tablet) and n is the release exponent related 
to the mechanism of the release. The n values used for 
the elucidation of the drug release mechanism from the 
tablets were determined from log cumulative percentage 
of drug released versus log time plots (i.e., log (Mt/M∞ × 
100) versus log t]. The release data were also analyzed as per 
Higuchi’s equation[13] Qt = K1t1/2, where Qt is the amount of 
drug released at time t and K1 is the diffusion rate constant. 
Table 2 shows an analysis of diffusional release mechanism 
obtained by various values of r2 and n.
Statistical analysis
The results are given as mean ± SD. The data were subjected 
to one way analysis of variance (ANOVA) for analyzing the 
statistical difference using the software PRISM (Graphpad, 
San Diego, CA). A confidence limit of P < 0.05 was fixed 
for interpretation of the results.
Stability studies
To determine any change in in vitro drug release profile 
on storage, stability studies were conducted using a 
stability chamber, Fatha instruments (Hum 1017) for F12 
formulation at 45° and 75% RH. The formulation was 
withdrawn after 4 weeks and evaluated for change in 
hardness, drug content and in vitro drug release pattern.
RESULTS AND DISCUSSION
The solubility studies of diltiazem hydrochloride at 
different pH buffer solutions indicate that it has very low 
solubility at basic pH. Indeed, its solubility at pH 3.6 is 
879.03 mg/mL, at pH 6.0 is 378.68 mg/mL, and at pH 
7.4 is reduced to 71.42 mg/mL. Further, the in vitro drug 
release characteristics of formulation F1 (without solubility 
modifier), exhibited the good dissolution profile of the 
initial 2 h (0.1 N HCl), but slowest dissolution in basic 
medium (phosphate buffer pH 7.4). The fact may be due 
to high pKa (7.5) value of diltiazem hydrochloride. Hence, 
in order to modify dissolution profile the decreasing pKa 
value of the tablet core would be ideal. Hence, commonly 
available organic acids with low pKa value were selected, 
such as citric acid, malic acid, and succinic acid were added 
in different ratios in to the formulation [Table 1].
The FT-IR spectra of drug, organic acid and physical 
Organic acids on diltiazem HCl release kinetics
Table 1: Formulation ingredients (all quantities are in mg)
Formulation Formulation ingredients
codes Diltiazem 
hydrochloride 
(mg)
HPMC (mg) Lactose (mg) Magnesium 
stearate (mg)
Citric acid  
(mg)
Malic acid  
(mg)
Succinic acid  
(mg)
F  1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12
F13
85
85
85
85
85
85
85
85
85
85
85
85
85
255
255
255
255
255
255
255
255
255
255
255
255
255
107.50
96.25
85.00
62.50
17.50
96.25
85.00
62.50
17.50
96.25
85.00
62.50
17.50
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
-
11.25
22.50
45.00
90.00
-
-
-
-
-
-
-
-
-
-
-
-
-
11.25
22.50
45.00
90.00
-
-
-
-
-
-
-
-
-
-
-
-
-
11.25
22.50
45.00
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mixture (1:1) of drug with organic acid showed [Figure 
1] no significance shift or reduction in intensity of peaks 
of drug. However, the IR spectra of physical mixture of 
drug with malic acid and succinic acid showed significance 
difference in the characteristic peaks of drug at 3450.77 
cm–1, but this is due to biotransformation of drug not by 
interaction with acids as it is confirmed.
The swelling index for HPMC was calculated with respect 
to time. It has been observed that the cumulative percent 
drug release decreases with increasing concentration of 
HPMC and swelling index. The reason attributed to this 
fact is slow erosion of the gelled layer from the tablets 
containing higher amount of HPMC [14-15]. The granules for 
tablet preparation were prepared according to the formula 
given in Table 1. Initially, tablets were prepared with a 
drug-to-polymer ratio of 1:1 and 1:2, water as a granulating 
agent. However, the drug release from these tablets was 
not uniform. Hence, the tablets with drug-to-polymer 
ratio of 1:3 were prepared to develop controlled drug 
delivery systems. The granules of different formulations 
were evaluated for angle of repose, loose bulk density 
(g/  mL), tapped bulk density (g/mL), and compressibility 
index (%). All these results indicate that the granules 
possessed satisfactory flow properties and compressibility. 
The tablets of all the formulations were subjected to 
various evaluation tests. All the tablet formulations have 
shown acceptable pharmacotechnical properties even 
at varying concentration of organic acids and complied 
with the in-house specifications for weight variation, drug 
content, hardness, and friability [Table 2]. The dissolution 
studies have shown that all the formulations had released 
a high-cumulative amount of drug at the end of 12 h 
compared to F1 formulation [Figure 2]. This may be due 
to acidic microenvironment of the polymer followed by 
incorporation of organic acids[16]. Further to confirm the 
added organic acid resulted in an acidic microenvironmental 
pH within the core of the tablet, 0.15% of methyl red was 
added to the matrix to visually monitor the pH value within 
the tablet during the drug release. The experiments showed 
that the tablet slowly turned to yellow from periphery 
toward the centre at basic pH 7.4.
To know the mechanism of drug release from these 
formulations, the data were treated according to Higuchi’s 
(cumulative percentage of drug released versus square root 
of time), and Korsmeyer et al.’s. (log cumulative percentage 
of drug released versus log time) equations. The release 
rate kinetic data for the selected formulations can be seen 
in Table 3. As clearly indicated, the formulations did not 
Table 2: Data obtained from evaluation of tablets*
Formulation code Hardness (kg/cm2) Friability (%) Drug content (%) Cumulative % drug 
release at 12th h
F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12
F13
6.0 ± 0.50
5.7 ± 0.29
5.3 ± 0.29
5.0 ± 0.00
4.3 ± 0.29
5.8 ± 0.29
5.3 ± 0.29
5.7 ± 0.29
4.3 ± 0.29
5.8 ± 0.29
5.3 ± 0.58
5.2 ± 0.29
4.3 ± 0.29
0.47 ± 0.02
0.65 ± 0.05
0.72 ± 0.07
0.72 ± 0.07
0.65 ± 0.08
0.73 ± 0.05
0.73 ± 0.05
0.78 ± 0.05
0.78 ± 0.05
0.67 ± 0.05
0.75 ± 0.10
0.70 ± 0.10
0.78 ± 0.07
97 ± 0.18
98 ± 0.08
97 ± 0.00
97 ± 0.08
97 ± 0.08
96 ± 0.20
99 ± 0.18
99 ± 0.18
99 ± 0.20
97 ± 0.18
96 ± 0.20
99 ± 0.08
97 ± 0.08
33 ± 0.60
48 ± 1.00
57 ± 1.00
64 ± 0.07
70 ± 1.00
46 ± 0.60
59 ± 1.00
65 ± 0.58
72 ± 1.30
49 ± 0.80
61 ± 1.50
77 ± 1.50
83 ± 0.58
All the values are given in ±SD (n = 3).
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Table 3: T50%, r2 and n values for selected formulations*
Formulation 
code
T50% (h) Correlation coefficient 
(Higuchi’s†) “r2”
Correlation coefficient 
(Peppa’s‡) “r2”
‘n’ Value  
(Peppa’s equation)
Mechanism of drug release
F3
F4
F5
F7
F8
F9
F11
F12
F13
10.52
09.37
08.57
10.16
09.23
08.33
09.83
07.79
07.22
0.978
0.989
0.995
0.981
0.975
0.987
0.981
0.955
0.986
0.990
0.994
0.991
0.992
0.994
0.983
0.996
0.996
0.985
0.628
0.640
0.519
0.690
0.710
0.515
0.703
0.778
0.580
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
Anomalous (non-Fickian)
†Higuchi’s equation, Qt = Kt1/2. ‡Korsmeyer et al.’s equation, Mt/M∞ = Ktn.J Young Pharm Vol 2 / No 3  233
follow a zero-order release pattern. Release of the drug from 
a matrix tablet containing hydrophilic polymers generally 
involves factors of diffusion. Diffusion is related to transport 
of drug from the dosage matrix into the in vitro study fluid 
depending on the concentration. As gradient varies, the 
drug is released, and the distance for diffusion increases. 
This could explain why the drug diffuses at a comparatively 
slower rate as the distance for diffusion increases, which is 
referred as square-root kinetics or Higuchi’s kinetics. In our 
experiments, the in vitro release profiles of drug from all the 
formulations could be best expressed by Higuchi’s equation, 
as the plots showed high linearity [Table 3]. To confirm the 
diffusion mechanism, the data were fit into Korsmeyer et al.’s 
equation. The formulations F2 to F13 showed good linearity 
(R2 = 0.983–0.996), with slope (n) values ranging from 0.515 
to 0.778, indicating that diffusion is the dominant mechanism 
of drug release with these formulations. When plotted 
according to Korsmeyer et al.’s equation, formulation F12 also 
showed high linearity (R2 = 0.996), with a comparatively high 
slope (n) value of 0.778. This n value, however, appears to 
indicate a coupling of diffusion and erosion mechanisms, 
i.e., anomalous diffusion.
There was a moderate improvement of drug release could 
be found when citric acid or malic acid was incorporated 
in to the matrix, but drug release was slower as compared 
with that of succinic acid tablets. No significant difference 
(P < 0.05) in release rate was observed between tablets 
containing 2.5%, 5.0% or 10% of citric acid or malic acid. 
However, drug release increased significantly (P < 0.05) 
with 10% of succinic acid [Table 2]. Further increase 
in concentration of succinic acid above 10% results in 
decreasing values of n and increasing values of k, in a 
linear relationship, which indicates may be there was a 
burst release of drug from the matrix with the addition of 
succinic acid above 10%. On this basis 10% succinic acid, 
F12 was considered ideal for tablet formulation.
Stability studies of F12 formulation revealed that there was 
no significant change in hardness, friability, drug content, 
and dissolution profiles. Thus, F12 formulation was stable at 
different conditions of temperature. Therefore, the use of 
organic acids with low pKa value, in matrix tablets makes 
possible a controlled release of diltiazem hydrochloride 
whose solubility is pH dependent.
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